;){kind=link}
Ms. Katrina Meng
Sales Manager
Sales Department
Address:
Room 201, Building 11, Zhejiang European & American Biotech Industrial Park, 501 Changsheng South Road, 314001, Jiaxing, Zhejiang, China
Telephone:
Zip Code:
Fax:
| Please sign in to view contact details |
Account Registered in:
2017
Business Range:
Chemicals, Health & Medicine
Management System Certification:
ISO 9001
Business Type:
Manufacturer/Factory
Company Introduction
Trade Capacity
Production Capacity
Biomatrik Inc. is a leading supplier of highly pure, monodispersed polyethylene glycol (PEG) products with various repeating units n (spacer length), end functional groups (X and Y) and various molecular architecture (linear, branched, and multi-armed).
PEGs has earned their place in the biomedical field due to their water solubility, non-toxicity, and non-immunogenicity properties. To date, ...
PEGs has earned their place in the biomedical field due to their water solubility, non-toxicity, and non-immunogenicity properties. To date, ...
Biomatrik Inc. is a leading supplier of highly pure, monodispersed polyethylene glycol (PEG) products with various repeating units n (spacer length), end functional groups (X and Y) and various molecular architecture (linear, branched, and multi-armed).
PEGs has earned their place in the biomedical field due to their water solubility, non-toxicity, and non-immunogenicity properties. To date, there are 12 pegylated drugs approved by the FDA to treat a number of chronic diseases.
While most PEG products are a mixture of different molecular weights, Biomatrik supplies monodispersed, single molecular weight molecules. Through our innovative technology, we have the ability to manufacture pure and monodispersed PEGs with precise molecular weights. Biomatrik developed the first acid functionalized PEG that is used to conjugate antibody and toxin (ADC drug) that will be launched commercially to treat breast cancer.
PEG's impact on biological therapies has increased the number of suppliers and manufacturers, but none have come close to our quality. Biomatrik stands as the world leader in PEG research and development.
PEGs has earned their place in the biomedical field due to their water solubility, non-toxicity, and non-immunogenicity properties. To date, there are 12 pegylated drugs approved by the FDA to treat a number of chronic diseases.
While most PEG products are a mixture of different molecular weights, Biomatrik supplies monodispersed, single molecular weight molecules. Through our innovative technology, we have the ability to manufacture pure and monodispersed PEGs with precise molecular weights. Biomatrik developed the first acid functionalized PEG that is used to conjugate antibody and toxin (ADC drug) that will be launched commercially to treat breast cancer.
PEG's impact on biological therapies has increased the number of suppliers and manufacturers, but none have come close to our quality. Biomatrik stands as the world leader in PEG research and development.
International Commercial Terms(Incoterms):
FOB, CIF
Terms of Payment:
T/T
Average Lead Time:
Peak Season Lead Time: within 15 workdays, Off Season Lead Time: one month
Number of Foreign Trading Staff:
4~10 People
Overseas Agent/Branch:
| Address | Telephone |
|---|---|
| 10459 Roselle St., Ste. H San Diego, CA 92121 USA, United States | 1 - 858 - 455 9778 |
Export Year:
2019-01-30
Export Percentage:
51%~70%
Main Markets:
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe
Factory Address:
Room 201, Building 11, Zhejiang European & American Biotech Industrial Park, 501 Changsheng South Road, 314001, Jiaxing, Zhejiang, China
R&D Capacity:
Own Brand()
No. of R&D Staff:
21-30 People
No. of Production Lines:
3
Annual Output Value:
US$2.5 Million - US$5 Million